Liquidia Corporation (LQDA) vs Nurix Therapeutics, Inc. (NRIX)
A side-by-side comparison of Liquidia Corporation and Nurix Therapeutics, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
LQDA
Liquidia Corporation
$26.32HealthcareDelayed quote: Oct 6, 2026, 2:30 PM EDT
NRIX
Nurix Therapeutics, Inc.
$22.55HealthcareDelayed quote: Oct 6, 2026, 2:25 PM EDT
Total return — LQDA vs NRIX
growth of $100 · dividends reinvested · last 6yLQDA +356.1% (+28.8%/yr)NRIX +20.4% (+3.1%/yr)LQDA compounded faster over this window
LQDA NRIX
LQDA vs NRIX: by the numbers
- •NRIX is the larger company ($2.34B vs $2.34B market cap).
- •LQDA is profitable (30.74% net margin) while NRIX runs a net loss (-928.44%).
- •LQDA grew revenue faster over the past five years (128.77% vs 9.96% CAGR).
Metrics side by side
Valuation
| Metric | LQDA | NRIX |
|---|---|---|
| P/E ratio | 19.22 | N/A |
| Forward P/E | 10.59 | N/A |
| P/S ratio | 5.19 | 63.66 |
| P/B ratio | 11.99 | 5.81 |
| EV / EBITDA | 12.83 | N/A |
| FCF yield | 2.59% | N/A |
Profitability
| Metric | LQDA | NRIX |
|---|---|---|
| Gross margin | 92.48% | 77.55% |
| Operating margin | -32.45% | -340.16% |
| Net margin | 30.74% | -928.44% |
| ROE | 71.04% | -84.78% |
| ROIC | 46.99% | -77.92% |
Growth (annualized)
| Metric | LQDA | NRIX |
|---|---|---|
| Revenue CAGR (5Y) | 128.77% | 9.96% |
| Total return CAGR (5Y) | 59.01% | -5.51% |
Frequently asked
- Which has grown faster, LQDA or NRIX?
- Over the past five years, LQDA grew revenue faster — LQDA at a 128.77% CAGR versus NRIX at 9.96%.
- Is LQDA or NRIX more profitable?
- LQDA runs the higher net margin — LQDA at 30.74% versus NRIX at -928.44%.
- How have LQDA and NRIX total returns compared?
- Over the past 5 years, LQDA delivered 59.01% and NRIX delivered -5.51% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Liquidia P/E ratioLiquidia ROENurix Therapeutics ROELiquidia operating marginNurix Therapeutics operating marginLiquidia revenue growthNurix Therapeutics revenue growthLiquidia free cash flowNurix Therapeutics free cash flow
Liquidia & Nurix Therapeutics appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.